Skip to content
Zimbabwe
-
Zimbabwe completes three-round polio vaccination drive to curb cross-border virus spread
The campaigns vaccinated 936,618 children during the first round, 997,941 during the second and 1,025,806 during the third.
-
Zimbabwe invests US$30M in cancer care upgrades in Mpilo and Parirenyatwa
The latest upgrades follow the recent arrival of advanced multi-energy radiotherapy machines destined for Mpilo and Parirenyatwa hospitals, part of a broader government initiative to improve access to specialised cancer treatment across Zimbabwe.
-
Zimbabwe’s Medicines Authority orders recall of Azithromycin over quality concerns
The recall specifically affects Azithromycin 500mg USP Tablets, Batch Number 24050191.
-
Zimbabwe recalls Urografin imaging agent due to cancer-risk impurity
The recall covers all batches of Urografin 60% manufactured between October 2020 and March 2025.
-
ZAMRA approves lenacapavir for HIV prevention in record time
The Zambia Medicines Regulatory Authority (ZAMRA) granted approval on November 4, 2025, completing its review in just 12 working days through an innovative regulatory pathway.